* Amedisys Inc AMED.OQ AMED.O is expected to show a rise
in
quarterly revenue when it reports results on July 24
(estimated) for the period ending June 30 2024
* The Baton Rouge Louisiana-based company is expected to
report a
4.7% increase in revenue to $578.825 million from $552.97
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Amedisys Inc is for
earnings
of $1.19 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 9
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Amedisys
Inc is
$101.00, above its last closing price of $97.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 1.03 1.02 1.03 Beat 1
Dec. 31 2023 1.02 1.03 0.94 Missed -8.9
Jan. 1 0001 1.06 1.08 0.98 Missed -9.2
Jun. 30 2023 1.09 1.09 1.37 Beat 25.5
Mar. 0.88 0.88 1.00 Beat 13.1
31 2023
Dec. 31 2022 0.97 1.00 1.16 Beat 15.5
Sep. 30 2022 1.21 1.22 1.15 Missed -5.5
Jun. 30 2022 1.23 1.23 1.47 Beat 19.5
This summary was machine generated July 22 at 12:47 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)